Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Clinical Trial ID NCT00677118

Rank	Title	Journal	Year	PubWeight™‹?›
1	Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.	Int J Radiat Oncol Biol Phys	2002	5.16
2	Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.	Int J Radiat Oncol Biol Phys	2004	3.59
3	Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.	Lancet Oncol	2011	2.75
4	[Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].	Ai Zheng	2004	1.41
5	A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients.	Int J Radiat Oncol Biol Phys	2002	1.28
6	Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study.	J Clin Oncol	1988	1.21
7	Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma.	Cancer	2003	1.17
8	Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations?	Int J Radiat Oncol Biol Phys	2001	1.07
9	Chemotherapy for nasopharyngeal carcinoma. A ten-year experience.	Cancer	1983	0.85
10	Chemotherapeutic management of head and neck cancer.	Cancer Metastasis Rev	1987	0.79